Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA607835
Max Phase: Preclinical
Molecular Formula: C60H93N13O10
Molecular Weight: 1156.48
Molecule Type: Protein
Associated Items:
ID: ALA607835
Max Phase: Preclinical
Molecular Formula: C60H93N13O10
Molecular Weight: 1156.48
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(N)cc2)NC1=O
Standard InChI: InChI=1S/C60H93N13O10/c1-34(2)30-43-53(76)68-45(32-38-16-10-9-11-17-38)59(82)72-28-14-20-47(72)55(78)70-49(36(5)6)57(80)65-42(19-13-27-62)52(75)67-44(31-35(3)4)54(77)69-46(33-39-22-24-40(63)25-23-39)60(83)73-29-15-21-48(73)56(79)71-50(37(7)8)58(81)64-41(18-12-26-61)51(74)66-43/h9-11,16-17,22-25,34-37,41-50H,12-15,18-21,26-33,61-63H2,1-8H3,(H,64,81)(H,65,80)(H,66,74)(H,67,75)(H,68,76)(H,69,77)(H,70,78)(H,71,79)/t41-,42-,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1
Standard InChI Key: IXYIARVZRHDNLA-SARDKLJWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1156.48 | Molecular Weight (Monoisotopic): 1155.7168 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. van der Knaap M, Engels E, Busscher HJ, Otero JM, Llamas-Saiz AL, van Raaij MJ, Mars-Groenendijk RH, Noort D, van der Marel GA, Overkleeft HS, Overhand M.. (2009) Synthesis and biological evaluation of asymmetric gramicidin S analogues containing modified D-phenylalanine residues., 17 (17): [PMID:19674904] [10.1016/j.bmc.2009.07.042] |
Source(1):